GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actuate Therapeutics Inc (NAS:ACTU) » Definitions » Dividend Payout Ratio

ACTU (Actuate Therapeutics) Dividend Payout Ratio : 0.00 (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Actuate Therapeutics Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Actuate Therapeutics's Dividend Payout Ratio for the months ended in Mar. 2025 was 0.00.

The historical rank and industry rank for Actuate Therapeutics's Dividend Payout Ratio or its related term are showing as below:


ACTU's Dividend Payout Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 0.47
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2025-07-20), the Dividend Yield % of Actuate Therapeutics is 0.00%.

Actuate Therapeutics's Dividends per Share for the months ended in Mar. 2025 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Actuate Therapeutics Dividend Payout Ratio Historical Data

The historical data trend for Actuate Therapeutics's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actuate Therapeutics Dividend Payout Ratio Chart

Actuate Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Dividend Payout Ratio
- - -

Actuate Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Actuate Therapeutics's Dividend Payout Ratio

For the Biotechnology subindustry, Actuate Therapeutics's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Actuate Therapeutics's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actuate Therapeutics's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Actuate Therapeutics's Dividend Payout Ratio falls into.


;
;

Actuate Therapeutics Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Actuate Therapeutics's Dividend Payout Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2024 )/ EPS without NRI (A: Dec. 2024 )
=0/ -3.292
=N/A

Actuate Therapeutics's Dividend Payout Ratio for the quarter that ended in Mar. 2025 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2025 )/ EPS without NRI (Q: Mar. 2025 )
=0/ -0.32
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Actuate Therapeutics (NAS:ACTU) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Actuate Therapeutics Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Actuate Therapeutics's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Actuate Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
1751 River Run, Suite 400, Fort Worth, TX, USA, 76107
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
Executives
Bios 2024 Co-invest, Lp director, other: Member of 10% Group 1751 RIVER RUN, SUITE 400, FORT WORTH TX 76107
Kairos Venture Partners Ii, L.p. director, other: 7.6% Owner 9440 SOUTH SANTA MONICA BLVD., #710, BEVERLY HILLS CA 90210
Bios Fund Iii Nt, Lp director, 10 percent owner 1751 RIVER RUN, SUITE 400, FORT WORTH TX 76107
Bios Fund Iii Qp, Lp director, 10 percent owner 1751 RIVER RUN, SUITE 400, FORT WORTH TX 76107
Bios Fund Iii, Lp director, 10 percent owner 1751 RIVER RUN, SUITE 400, FORT WORTH TX 76107
Bios Equity Partners Iii, Lp director, 10 percent owner 1751 RIVER RUN, SUITE 400, FORT WORTH TX 76107
Roger Sawhney director C/O OMEGA THERAPEUTICS, INC., 20 ACORN PARK D, CAMBRIDGE MA 02140
Dan Zabrowski director C/O APEXIGEN INC, 75 SHOREWAY ROAD, SUITE C, SAN CARLOS CA 94070
Daniel M Schmitt director, officer: President, CEO and Director C/O IMMTECH INTERNATIONAL INC, 150 FAIRWAY DRIVE SUITE 150, VERNON HILLS IL 60061
Bios Capital Management, Lp director, 10 percent owner 1751 RIVER RUN, SUITE 400, FORT WORTH TX 76107
Bios Actuate Co-invest I, Lp director, 10 percent owner 1751 RIVER RUN, SUITE 400, FORT WORTH TX 76107
Kairos Venture Opportunities I, L.p. director, other: 5.3% Owner 9440 SOUTH SANTA MONICA BLVD., SUITE 710, BEVERLY HILLS CA 90210
Kairos Spv Fund Llc director, other: 2% Owner 9440 SOUTH SANTA MONICA BOULEVARD, #710, BEVERLY HILLS CA 90210
Bios Actuate Co-invest Ii, Lp director, 10 percent owner 1751 RIVER RUN, SUITE 400, FORT WORTH TX 76107
Kairos-actuate Spv, L.p. director, other: 1.5% Owner 9440 SOUTH SANTA MONICA BOULEVARD, SUITE 710, BEVERLY HILLS CA 90210

Actuate Therapeutics Headlines

From GuruFocus